Lymphocytic colitis secondary to ipilimumab treatment

Inflammatory Bowel Diseases

Volumn 19, Issue 2, 2013, Pages

  García Varona, Alejandro ^a   Odze, Robert D ^b   Makrauer, Frederick ^b  

^a HOSPITAL EL BIERZO   (Spain)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; IPILIMUMAB;

ABDOMINAL DISCOMFORT; AGED; CANCER STAGING; CASE REPORT; CD4+ T LYMPHOCYTE; COMPASSIONATE USE; CYTOKINE RELEASE; DESCENDING COLON; DIARRHEA; ENTEROCOLITIS; GASTROINTESTINAL TOXICITY; HUMAN; LAMINA PROPRIA; LETTER; LYMPHOCYTE; LYMPHOCYTIC COLITIS; MALE; MELANOMA; PHASE 3 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL;

AGED; ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC AGENTS; COLITIS, LYMPHOCYTIC; HUMANS; MALE;

EID: 84876418656     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.22846     Document Type: Letter

References (8)

1. [No authors listed]. Ipilimumab. Drugs R D. 2010;10: 97-110.
2. Wolchok JD, Neyns B, Linette G, et al. Ipilimumab monotherapy in patients with pre-treated advanced melanoma: a randomised, double-blind, multicentre, phase 2, dose-ranging study. Lancet Oncol. 2010;11:155-164.
3. Hodi FS, O'Day SJ, McDermott DF, et al. Improved survival with ipilimumab in patients with metastatic melanoma. N Engl J Med. 2010;363:711-723.
4. Oble DA, Mino-Kenudson M, Goldsmith J, et al. a-CTLA-4 mAb-associated panenteritis. A histologic and immunohistochemical analysis. Am J Surg Pathol. 2008;32:1130-1137.
5. Berman D, Parker SM, Siegel J, et al. Blockade of cytotoxic T-lymphocyte antigen-4 by ipilimumab results in dysregulation of gastrointestinal immunity in patients with advanced melanoma. Cancer Immun. 2010;10:11.
6. Beck KE, Blansfield JA, Tran KQ, et al. Enterocolitis in patients with cancer after antibody blockade of cytotoxic T-lymphocyte-associated antigen 4. J Clin Oncol. 2006;24: 2283-2289.
7. Beelen DW, Elmaagacli A, Muller KD, et al. Influence of intestinal bacterial decontamination using metronidazole and ciprofloxacin or ciprofloxacin alone on the development of acute graft-versus-host disease after marrow transplantation in patients with hematologic malignancies: final result and long-term follow-up of an open-label prospective randomized trial. Blood. 1999;93:3267-3275.
8. Mottet C, Uhlig HH, Powrie F. Cutting edge: cure of colitis by CD4+CD25+ regulatory T cells. J Immunol. 2003;170:3939-3943.